Astrazeneca Share News (AZN)

Novo says Wegovy drug helps obese people with heart failure in trial

Aug 25 (Reuters) - Novo Nordisk said its hugely popular drug Wegovy was shown to substantially ease heart failure in obese people, as the Danish drugmaker seeks to further build its case for the medicine's health benefits beyond weight loss.

UPDATE: AstraZeneca, Merck & Co say Lynparza approved in Japan

(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Thursday jointly said its Lynparza treatments have been approved in Japan.

AstraZeneca says Soliris and Lynparza approved in Japan

(Alliance News) - AstraZeneca PLC on Thursday said both its Soliris and Lynparza treatments have been approved in Japan.

AstraZeneca facing two London lawsuits over COVID-19 vaccines

LONDON, Aug 23 (Reuters) - AstraZeneca is facing two London lawsuits, including one from the husband of a woman who died after receiving the Anglo-Swedish drugmaker's COVID-19 vaccine, in the first of potentially dozens of cases brought in England.

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Daiichi Sankyo and AstraZeneca's Enhertu wins new approval in Japan

(Alliance News) - AstraZeneca PLC's partner Daiichi Sankyo Co Ltd on Wednesday announced that their cancer drug Enhertu has received another approval in Japan.

Pay for FTSE 100 bosses jumps 16% as wider wages behind inflation

(Alliance News) - The bosses of Britain's biggest companies saw their pay surge by 16% last year as most workers saw their pay packets outstripped by inflation, according to new research.

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Britain's CEOs get 16% pay rise to 3.9 mln pounds even as workers struggle

LONDON, Aug 21 (Reuters) - The bosses of Britain's biggest companies saw their pay jump 16% in 2022, sending their average earnings to 118 times the median UK full-time worker's while employees struggled with soaring inflation, new research showed on Monday.

AstraZeneca hails new data on Forxiga's impact on heart failure

(Alliance News) - AstraZeneca PLC on Monday announced that new data from its studies show positive effects of Forxiga on people with heart failure.

European shares sink to lowest in six weeks, China woes loom large

China-exposed firms fall on growth concerns

*

TOP NEWS: AstraZeneca hails heart-focused Forxiga approval in China

(Alliance News) - AstraZeneca PLC on Friday said its drug Forxiga has been approved in China for some adults to reduce the risk of cardiovascular death and hospitalisation.

FTSE 100 hits one-month low as record UK wage growth drives pound higher

UK basic wage growth hits record

*

Murphy Canyon to hold meeting on planned buy of interest in AZD1656

(Alliance News) - Cizzle Biotechnology PLC and Vela Technologies PLC on Tuesday noted that blank-check special purpose acquisition company Murphy Canyon Acquisition Corp will hold a special meeting on September 7.

LONDON MARKET MIDDAY: FTSE 100 flat, peers and pound up before US data

(Alliance News) - London's FTSE 100 underwhelmed on Thursday, as a slew of its heavyweights went ex-dividend, though blue-chip equities in mainland Europe were higher, showing no signs of pre-US inflation data angst and overlooking an acceleration in tensions between the world's two largest economies.